News and Events
Shared sepsis / severe COVID-19 genetic risk factors with 59 potential drug re-purposing candidates identified in fight against COVID-19
Using PrecisionLife's proprietary AI enabled precision medicine platform we have identified 59 re-purposing drug candidates that could be used to develop new therapeutic strategies to increase the survival rate of patients who develop sepsis while suffering from...
Tackling Coronavirus with Digital Technologies – Virtual Conference and Networking Event, Wednesday 8th April, 2020, from 2pm
PrecisionLife CEO & Founder Dr Steve Gardner will be taking part in an expert panel discussion at a Virtual Conference and Networking Event looking at ‘Digital Medicine Solutions for COVID-19’ on Wednesday April 8th at 2pm. Organised by the International Society...
PrecisionLife offers analytics and resource support to COVID-19 coronavirus research community
PrecisionLife has confirmed it is extending its relationships with some of the largest COVID-19 collaborative research projects and is now offering free use of its unique analytics platform and support from its data and biomedical science teams to the on-going...
PrecisionLife and PharmEnable partner in search for new ALS treatments
26th November 2019, Oxford and Cambridge, United Kingdom PrecisionLife and PharmEnable have announced a new drug discovery partnership, collaborating to develop novel treatments for Amyotrophic Lateral Sclerosis (ALS). They are joined by disease researchers at the...
RowAnalytics becomes PrecisionLife in exciting rebrand and new website
Building on its guiding principles of insight and innovation, AI-enabled precision medicine company RowAnalytics Ltd has undertaken a comprehensive rebrand to become PrecisionLife Ltd, culminating in the launch of a new website and early-stage partnering model. The...